A unique recombinant protein overexpression system will be investigated for the production of phosphotriesterase, an organophosphate hydrolase from Pseudomonas diminuta MG and Flavobacterium sp. ATCC 27551. This enzyme is a leading bioremediation candidate for large-scale detoxification of insecticides and chemical warfare agents. The hydrolase will be prepared in three different versions using this novel system. A soluble form, a membrane-bound version and a fusion protein suitable for biosensor applications will be attempted. This versatile expression vehicle could be very effective for membrane protein applications, an important niche where systems currently available have been shown to be inadequate. Furthermore, the low-cost nature of this system is very attractive for large-scale protein production purposes.This system will occupy an important niche market where expression systems currently available commercially are not effective. This system can be used for the mass production of medicinally important membrane proteins and in structural genomics efforts of membrane proteins. The recombinant membrane proteins can be marketed for use in high-throughput screening, in structural biology efforts of medicinally important membrane proteins hence crucil in structure-based drug design endeavors.
Keywords: Overexpression System, Organophosphorous Hydrolase, Recombinant Soluble & Membrane Proteins
